Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same de1521-T mutation

被引:34
作者
Kefi, M
Amouri, R
Driss, A
Ben Hamida, C
Ben Hamida, M
Kunkel, LM
Hentati, F
机构
[1] Inst Natl Neurol, Lab Neurobiol Mol & Neuropathol, Tunis 1007, Tunisia
[2] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA
[3] Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA
关键词
LGMD; 2C; sarcoglycanopathy; genotype-phenotype correlation; sarcoglycan complex; GIRDLE MUSCULAR-DYSTROPHIES; GAMMA-SARCOGLYCAN; INTESTINAL NEOPLASIA; BETA-SARCOGLYCAN; MAJOR MODIFIER; GENE; IDENTIFICATION; LOCUS; COMPLEX; GLYCOPROTEIN;
D O I
10.1016/S0960-8966(03)00136-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Limb-girdle muscular dystrophy type 2C is an autosomal recessive muscular disorder caused by mutations in the gene encoding the gamma-sarcoglycan subunit. This gamma-sarcoglycanopathy is prevalent in Tunisia where only one homozygous mutation a 521-T deletion has been identified. The aim of this study was to carry out a comparative clinical and immunocytochemical analysis of Tunisian patients sharing the same gamma-sarcoglycan gene mutation. One hundred and thirty-two patients were classified as severe, moderate or mild according to a calculated severity score. Heterogeneous phenotypes between siblings were encountered in 75% of the families. The severity of the disease was not found to be related to the age of onset. Immunohistochemical studies of muscle biopsy showed a total absence of gamma-sarcoglycan, a normal or slightly reduced alpha and delta-sarcoglycans whereas the expression of beta-sarcoglycan was variable. The residual sarcoglycan expression was not related to the clinical phenotype. In conclusion, the phenotypic variability in sarcoglycanopathies in Tunisia seems to involve a modifying gene controlling the course of the disease. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:779 / 787
页数:9
相关论文
共 32 条
[1]   Limb-girdle muscular dystrophy 2C: Clinical aspects [J].
BenHamida, M ;
BenHamida, C ;
Zouari, M ;
Belal, S ;
Hentati, F .
NEUROMUSCULAR DISORDERS, 1996, 6 (06) :493-494
[2]   LINKAGE OF TUNISIAN AUTOSOMAL RECESSIVE DUCHENNE-LIKE MUSCULAR-DYSTROPHY TO THE PERICENTROMERIC REGION OF CHROMOSOME 13Q [J].
BENOTHMANE, K ;
BENHAMIDA, M ;
PERICAKVANCE, MA ;
BENHAMIDA, C ;
BLEL, S ;
CARTER, SC ;
BOWCOCK, AM ;
PETRUKHIN, K ;
GILLIAM, TC ;
ROSES, AD ;
HENTATI, F ;
VANCE, JM .
NATURE GENETICS, 1992, 2 (04) :315-317
[3]   Primary γ-sarcoglycanopathy (LGMD 2C):: broadening of the mutational spectrum guided by the immunohistochemical profile [J].
Bönnemann, CG ;
Wong, J ;
Jones, KJ ;
Lidov, HGW ;
Feener, CA ;
Shapiro, F ;
Darras, BT ;
Kunkel, LM ;
North, KN .
NEUROMUSCULAR DISORDERS, 2002, 12 (03) :273-280
[4]   BETA-SARCOGLYCAN (A3B) MUTATIONS CAUSE AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY WITH LOSS OF THE SARCOGLYCAN COMPLEX [J].
BONNEMANN, CG ;
MODI, R ;
NOGUCHI, S ;
MIZUNO, Y ;
YOSHIDA, M ;
GUSSONI, E ;
MCNALLY, EM ;
DUGGAN, DJ ;
ANGELINI, C ;
HOFFMAN, EP ;
OZAWA, E ;
KUNKEL, LM .
NATURE GENETICS, 1995, 11 (03) :266-273
[5]   ASSOCIATION OF DYSTROPHIN AND AN INTEGRAL MEMBRANE GLYCOPROTEIN [J].
CAMPBELL, KP ;
KAHL, SD .
NATURE, 1989, 338 (6212) :259-262
[6]   GENETIC IDENTIFICATION OF MOM-1, A MAJOR MODIFIER LOCUS AFFECTING MIN-INDUCED INTESTINAL NEOPLASIA IN THE MOUSE [J].
DIETRICH, WF ;
LANDER, ES ;
SMITH, JS ;
MOSER, AR ;
GOULD, KA ;
LUONGO, C ;
BORENSTEIN, N ;
DOVE, W .
CELL, 1993, 75 (04) :631-639
[7]   Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis [J].
Dobbie, Z ;
Heinimann, K ;
Bishop, DT ;
Muller, H ;
Scott, RJ .
HUMAN GENETICS, 1997, 99 (05) :653-657
[8]  
Draviam R, 2001, MUSCLE NERVE, V24, P262, DOI 10.1002/1097-4598(200102)24:2<262::AID-MUS120>3.0.CO
[9]  
2-3
[10]   Juvenile limb-girdle muscular dystrophy Clinical, histopathological and genetic data from a small community living in the Reunion Island [J].
Fardeau, M ;
Hillaire, D ;
Mignard, C ;
Feingold, N ;
Feingold, J ;
Mignard, D ;
deUbeda, B ;
Collin, H ;
Tome, FMS ;
Richard, I ;
Beckmann, J .
BRAIN, 1996, 119 :295-308